IL-12 Inhibitors

The chemical class of IL-12 inhibitors comprises a range of compounds primarily characterized by their ability to modulate immune responses and cytokine production, thereby indirectly influencing IL-12 levels. These compounds achieve this through various mechanisms, including the inhibition of key signaling pathways and transcription factors involved in cytokine synthesis. One primary mechanism by which these inhibitors operate is through the modulation of NF-κB, a critical transcription factor in the regulation of immune responses and cytokine production. Compounds such as dexamethasone, apigenin, curcumin, resveratrol, sulforaphane, quercetin, wogonin, and genistein exert their inhibitory effects on IL-12 by suppressing NF-κB activation. This suppression leads to a decreased production of IL-12, as NF-κB plays a significant role in the transcriptional activation of this cytokine. For instance, curcumin, a well-known anti-inflammatory compound, inhibits NF-κB activation, thereby reducing IL-12 production. Similarly, apigenin and quercetin, both flavonoids, modulate NF-κB and JNK pathways, leading to decreased IL-12 synthesis.

Another method of IL-12 inhibition is via the reduction of prostaglandin synthesis. Aspirin and indomethacin, both non-steroidal anti-inflammatory drugs (NSAIDs), inhibit cyclooxygenase enzymes, leading to reduced prostaglandin production. This reduction can subsequently decrease IL-12 synthesis, as prostaglandins are known to modulate cytokine production. Additionally, corticosteroids like hydrocortisone suppress overall immune responses and cytokine production, including IL-12, contributing to their role as indirect IL-12 inhibitors. Stigmasterol, a plant sterol, represents another approach to modulating immune responses and potentially reducing IL-12 levels. By influencing various aspects of the immune system, stigmasterol can contribute to the overall regulation of cytokine production.